Pulse Biosciences (PLSE) Other Non-Current Assets (2017 - 2025)
Pulse Biosciences (PLSE) recorded quarterly Other Non-Current Assets of $691000.0 in Q4 2025, down 1.99% quarter-over-quarter from $705000.0 in Q3 2025, and up 2.07% on a YoY basis from $677000.0 in Q4 2024.
Pulse Biosciences (PLSE) Other Non-Current Assets (2017 - 2025) Analysis & Trends
Pulse Biosciences' Other Non-Current Assets history runs 9 years deep, the most recent figure standing at $691000.0 for Q4 2025.
- In Q4 2025, Other Non-Current Assets rose 2.07% year-over-year to $691000.0; the TTM figure through Dec 2025 stood at $691000.0 (up 2.07% YoY), while the FY2025 annual figure was $691000.0, up 2.07% from the prior year.
- Other Non-Current Assets was $691000.0 for Q4 2025 at Pulse Biosciences, down from $705000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $714000.0 in Q2 2024 to a low of $365000.0 in Q1 2021.
- Historically, Other Non-Current Assets has averaged $476650.0 across 5 years, with a median of $365000.0 in 2021.
- The sharpest annual moves came in 2021 and 2024: Other Non-Current Assets sank 35.05% in 2021, then jumped 95.62% in 2024.
- A 5-year view of Other Non-Current Assets shows it stood at $365000.0 in 2021, then changed by 0.0% to $365000.0 in 2022, then changed by 0.0% to $365000.0 in 2023, then surged by 85.48% to $677000.0 in 2024, then rose by 2.07% to $691000.0 in 2025.
- The last three Other Non-Current Assets figures came in at $691000.0 (Q4 2025), $705000.0 (Q3 2025), and $677000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 2.43 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 446.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 210.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 81.30 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 848.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 672.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 39.83 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 692.00 Mn |
| 10 | Pulse Biosciences | 1.68 Bn | 1.68 Bn | - | 691,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 691,000.00 |
| Sep 30, 2025 | 705,000.00 |
| Jun 30, 2025 | 677,000.00 |
| Mar 31, 2025 | 678,000.00 |
| Dec 31, 2024 | 677,000.00 |
| Sep 30, 2024 | 646,000.00 |
| Jun 30, 2024 | 714,000.00 |
| Mar 31, 2024 | 365,000.00 |
| Dec 31, 2023 | 365,000.00 |
| Sep 30, 2023 | 365,000.00 |
| Jun 30, 2023 | 365,000.00 |
| Mar 31, 2023 | 365,000.00 |
| Dec 31, 2022 | 365,000.00 |
| Sep 30, 2022 | 365,000.00 |
| Jun 30, 2022 | 365,000.00 |
| Mar 31, 2022 | 365,000.00 |
| Dec 31, 2021 | 365,000.00 |
| Sep 30, 2021 | 365,000.00 |
| Jun 30, 2021 | 365,000.00 |
| Mar 31, 2021 | 365,000.00 |